Next-Generation Sequencing with Liquid Biopsies from Treatment-Naïve Non-Small Cell Lung Carcinoma Patients

SIMPLE SUMMARY: Screening for genomic alterations in treatment-naïve non-small cell lung carcinoma (NSCLC) is mainly done by tissue biopsy (TB), an invasive approach. However, it may not be possible to obtain a TB, the patient does not consent to it and/or the extracted nucleic acids are of poor qua...

Descripción completa

Detalles Bibliográficos
Autor principal: Hofman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122958/
https://www.ncbi.nlm.nih.gov/pubmed/33922637
http://dx.doi.org/10.3390/cancers13092049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122958/
https://www.ncbi.nlm.nih.gov/pubmed/33922637
http://dx.doi.org/10.3390/cancers13092049

Ejemplares similares